Produktbild: Nanocarrier Vaccines

Nanocarrier Vaccines Biopharmaceutics-Based Fast Track Development

249,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

12.03.2024

Herausgeber

Vivek P. Chavda + weitere

Verlag

John Wiley & Sons Inc

Seitenzahl

528

Maße (L/B/H)

15,9/23,8/3,6 cm

Gewicht

1025 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-1-394-17468-3

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

12.03.2024

Herausgeber

Verlag

John Wiley & Sons Inc

Seitenzahl

528

Maße (L/B/H)

15,9/23,8/3,6 cm

Gewicht

1025 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-1-394-17468-3

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Nanocarrier Vaccines
  • Preface xxi
     
    Part 1 General 1
     
    1 History of Nanoparticles 3
    Keshava L. Jetha, Arya Vyas, Divya Teli, Amit Chaudhari, Riyansi Satasiya, Vishwa Patel, Shailvi Soni, Shail Modi and Vasso Apostolopoulos
     
    1.1 Introduction 4
     
    1.2 History of Nanoparticles 5
     
    1.3 Modern Development of Nanoparticles 8
     
    1.4 Type of Nanoparticles 10
     
    1.5 Properties of Nanoparticles 13
     
    1.6 Importance of Nanoparticles 15
     
    1.7 Conclusion and Future Prospect 18
     
    2 Composition of Nanoparticles 25
    Amit Chaudhari, Palak Vadodariya, Arya Vyas, Disha Patel and Divya Teli
     
    2.1 Introduction 25
     
    2.2 Types of Nanoparticles 27
     
    2.3 Composition of Nanoparticles 40
     
    2.4 Synthesis of Nanoparticles 45
     
    2.5 Nanoparticle Characterization by Various Instrumental Techniques 50
     
    2.6 Understanding Nanotoxicity: Potential Risks and Implications 53
     
    2.7 Conclusion 54
     
    3 Nanotechnology and Vaccine Development 63
    Keshava L. Jetha, Praful D. Bharadia and Manish P. Patel
     
    3.1 Introduction 63
     
    3.2 Overview of Vaccine Development 64
     
    3.3 Advantages of Nanoparticles in Vaccine Delivery 66
     
    3.4 Types of Nanoparticles as Vaccine Carriers 67
     
    3.5 Development of Nanoparticle-Based Vaccine 70
     
    3.6 Adjuvants and their Role in Vaccine Development 72
     
    3.7 Nanoscale Adjuvants 74
     
    3.8 Advantages 75
     
    3.9 Techniques for Nanoscale Adjuvants 76
     
    3.10 Route of Administration for Vaccines 77
     
    3.11 Recent Advances in Nanotechnology-Based Vaccines 79
     
    3.12 The Regulatory Perspective of Nanoparticle-Based Vaccine Development 80
     
    3.13 Future Prospects 81
     
    3.14 Conclusion 84
     
    4 Nanoparticle Formulations: A Sustainable Approach to Biodegradable and Non-Biodegradable Products 95
    Amandeep Singh, Shreni Parikh, Nutan Sethi, Sachin Patel, Nrupal Modi and Kaushika Patel
     
    4.1 Introduction 96
     
    4.2 Types of Nanoparticles 96
     
    4.3 Preparation of Nanoparticles 100
     
    4.4 Factors Affecting Selection of Method 100
     
    4.5 Polymers Used in NP Formulation 107
     
    4.6 Nanoparticle Formulations Based on Biodegradable Polymers 107
     
    4.7 Nanoparticle Formulations Based on Non-Biodegradable Polymers 115
     
    4.8 Nanoparticle Formulations Based on Natural Polymers 118
     
    4.9 Challenges in NPs from Laboratory to Industrial Scale-Up 121
     
    4.10 Nanoparticle-Based Approved & Marketed Formulations 122
     
    4.11 Future Aspects & Conclusion 122
     
    5 Nanoparticle Properties: Size, Shape, Charge, Inertness, Efficacy, Morphology 153
    Kajal P. Baviskar, Brijesh M. Shah, Anjali P. Bedse, Shilpa S. Raut, Suchita P. Dhamane and Dhara J. Dave
     
    5.1 Introduction 154
     
    5.2 Applications of Nanoparticle Formulations 155
     
    5.3 Interaction with Cells 157
     
    5.4 Properties of Nanoparticles 159
     
    5.5 Role of Physicochemical Properties in Nanoparticle Toxicity 174
     
    5.6 Conclusion 177
     
    Part 2 Nanoparticles to Deliver Antigen 193
     
    6 Viral Vector-Based Nanoparticles 195
    Suneetha Vuppu, Vivek P. Chavda, Toshika Mishra, Oishani Sengupta, Anand Sairam, Paridhi Soni, Mohit Joshi, Bhumi Bhalodiya and Raj V.
     
    6.1 Introduction 196
     
    6.2 Characteristics of Viral Vector-Based Nanoparticles 197
     
    6.3 Applications 199
     
    6.4 Novel Advancements in Applications of Viral Nanoparticles 225
     
    6.5 Limitations and Prospects of Viral Vector-Based Nanoparticle Approach 233
     
    6.6 Conclusion 234
     
    7 Lipid-Based Nanoparticles 241
    Sunny Shah, Hardik Madhu, Moinuddin Soniwala, Dhaval Mor